2016-10-29T04-45-55Z
Source: The Southeast Asian Journal of Case Report and Review
Mudasir Mushtaq, Maqbool Wani, Mushtaq Ahmed Wani, Rouf Asimi, Sawan Verma, Irfan Shah.
MGN is the most common form of glomerulonephritis causing nephritic syndrome in adults. Cases have been reported depicting association between MGN and neurological diseases like guillain-barre syndrome, multiple sclerosis and chronic inflammatory demyelinating polyneuropathy . However only one case has been reported with MGN and inflammatory myelopathy. Our patient was 36 yrs old female admitted with paraparesis and paresthesias in bilateral hands with bowel and bladder involvement and she had a biopsy documented episode of membranous nephropathy.
http://ift.tt/2eljoU1
Σάββατο 29 Οκτωβρίου 2016
Membranous Nephropathy With Transverse Myelitis
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Pulmonary complications post hematopoietic stem cell transplant in dyskeratosis congenita: analysis of oxidative stress in lung fibrobl...
-
Predictive Success Factors in Selective Upper Airway Stimulation. ORL J Otorhinolaryngol Relat Spec. 2017 Feb 24;79(1-2):121-128 Auth...
-
Background. Antitumor necrosis factor (anti-TNF) therapy is a highly effective but costly treatment for inflammatory bowel disease (IBD). Me...
-
Abstract Nonmotor symptoms (NMS) have been described in several neurodegenerative diseases but have not been systematically evaluated in sp...
-
Abstract Background The introduction of aggressive chemo-radiotherapy regimens has improved overall survival in children with primitive ...
-
6 Top Reference Sites to Write a Winning Research Paper . Tina 6 Top Reference Sites to Write a Winning Research Paper. There may be guideli...
-
Elementary school kids, on the other hand, can read, write, reason and think highly complex thoughts. Adele Faber and Elaine Mazlish, author...
-
by Mindaugas Paužuolis, Torsten Eich, Joachim Burman Background Natalizumab (NTZ) is a drug that has been widely used in the treatment of m...
-
Abstract Purpose To develop the first photoactive biomaterial coating capable of controlled drug dosing via inclusion of synthesised drug-...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου